Emotional Awareness Therapy Study
TREAT
A Feasibility Study Exploring Emotional Health Training After Moderate to Severe Traumatic Brain Injury
1 other identifier
interventional
48
1 country
1
Brief Summary
The purpose of this study is to learn about the potential benefits of two different training programs in helping improve emotional health and well-being in people who have had a traumatic brain injury. Participants will be assigned to one of two programs based on the time since their injury. One of the programs will teach participants how to recognize and label emotions; the other will teach healthy ways of living. Participants may improve their emotional well-being and contribute to the knowledge needed to achieve better emotional health outcomes for people with TBI. For eligible participants, the study includes 4 assessments. Assessments may take 30-60 minutes and will be done using secure videoconferencing, phone calls, and/or electronic surveys. The first assessment will ask questions about demographics, the participant's brain injury, and some medical history. All assessments will include questions about emotions, emotional awareness, resilience, loneliness, and how participants manage emotions, in addition to broader wellness questions and questions about how participants interact with others. Regardless of the program, the training includes 8 one-on-one sessions with a trained staff member over the course of about 1 month. Each session will last approximately 60-90 minutes. These sessions will start shortly after completing the first assessment. Preferably, participants will complete 1-2 training sessions a week, depending on availability and preference. These sessions will include education, discussion, and practice exercises. After the program is finished, participants will be asked to complete the same surveys completed at baseline for three follow-up time points (immediately following the program, 3 months after the program, and 6 months after). Total participation in the study will last approximately 8 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2028
June 3, 2026
May 1, 2026
2 years
May 20, 2026
May 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Ineligibility and Attrition Rates
Data will be tracked on the number of individuals who were ineligible (and reasons for ineligibility) as well as withdrawals (reasons for withdrawal) and /or number of participants who become "lost" (no longer able to contact).
Through study completion, an average of 8 months
Satisfaction Survey and Interview
Range: Min/ Max = 1 to 5 Lower scores are worse; higher scores are more satisfied
immediate post-treatment
Interventionist Evaluation of Session Participation
Range: Min/Max = 6 to 24 Internal assessment completed by the interventionist at the end of each training session.
intervention training sessions 1-8 (approximately 8 months)
Patient Global Impression of Change (PGIC) emotional functioning and quality of life
Range: Min/ Max = 1 to 7 Lower scores are worse; higher scores are better.
immediate post-treatment
Care-partner Global Impression of Change (CGIC) emotional functioning and quality of life
Range: Min/ Max = 1 to 7 Lower scores are worse; higher scores are better.
immediate post-treatment
Secondary Outcomes (3)
Toronto Alexithymia Scale-20
1) baseline 2) immediate post-treatment, 3) 3 months post-treatment; 4) 6- months post-treatment.
Difficulty with Emotion Regulation Scale (DERS; Co-Primary outcome)
1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months
Brief Resilience Scale
1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months
Study Arms (2)
TREAT-A
EXPERIMENTALEight lessons delivered by a trained team member (interventionist) to the participant over \~4 weeks. It involves psycho-educational lessons and skill-building exercises to achieve the following objectives based on the characteristics of alexithymia.: 1) learn benefits of emotional awareness; 2) improve threshold for earlier detection of emotional responses; 3) label and differentiate emotions; 4) experience range of emotions; and 5) distinguish emotions from thoughts, actions and sensations.
TREAT-B
ACTIVE COMPARATORProvides education on TBI and overall brain health through instructional sessions, discussion, and structured tasks geared towards living healthy and improving general well-being.
Interventions
The TREAT-A program will teach participants how to recognize, label, and differentiate their emotions. The program will cover ways to reduce feeling "confused" or numb, and decrease the feelings of anger, stress and being overwhelmed.
The TREAT-B program will teach participants strategies to improve their overall brain health and functioning. It will also teach participants how to develop and work towards individualized short-term and long-term goals aimed at improving their quality of life.
Eligibility Criteria
You may qualify if:
- Moderate or Severe TBI
- ≥18 years old
- ≥6 months post-TBI
- Speaks and understands English
- Medications that can influence mood should be stable (6+ weeks)
- Elevated alexithymia
- Demonstrate an understanding of the study and their rights (e.g. ability to answer the following questions correctly after a review of the study details during pre-screening process)
You may not qualify if:
- Premorbid neurological disorder other than TBI
- Degenerative neurologic condition
- Active or uncontrolled major psychiatric disorder
- Conditions that pose safety concern to self or others, such as suicide risk
- Visual, hearing, communication, or cognitive impairments that would impede participation
- Active involvement in an intensive rehabilitation program
- Individuals who recently started psychotherapy and/or mental health counseling
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute
Edison, New Jersey, 08820, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dawn Neumann, PhD, FACRM
Hackensack Meridian Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2026
First Posted
June 3, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
May 31, 2028
Study Completion (Estimated)
May 31, 2028
Last Updated
June 3, 2026
Record last verified: 2026-05